dalteparin has been researched along with Cholecystitis, Acute in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cholecystitis, Acute: Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90% of the cases.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galimov, OV | 1 |
Galeev, FS | 1 |
Khanov, VO | 1 |
Mukhametov, AR | 1 |
Andreev, PP | 1 |
Muslimova, LR | 1 |
Aminova, LN | 1 |
1 other study available for dalteparin and Cholecystitis, Acute
Article | Year |
---|---|
[Some aspects of abdominal surgical interventions in the presence of obesity].
Topics: Anticoagulants; Cholecystitis, Acute; Female; Follow-Up Studies; Hernia, Diaphragmatic; Hernia, Vent | 2008 |